SARS-CoV-2 nucleocapsid protein interaction with YBX1 displays oncolytic properties through PKM mRNA destabilization

Xin Chen,Baohong Jiang,Yu Gu,Zhaoyang Yue,Ying Liu,Zhiwei Lei,Ge Yang,Minhua Deng,Xuelong Zhang,Zhen Luo,Yongkui Li,Qiwei Zhang,Xuepei Zhang,Jianguo Wu,Chunyu Huang,Pan Pan…
DOI: https://doi.org/10.1186/s12943-024-02153-1
IF: 37.3
2024-11-07
Molecular Cancer
Abstract:SARS-CoV-2, a highly contagious coronavirus, is responsible for the global pandemic of COVID-19 in 2019. Currently, it remains uncertain whether SARS-CoV-2 possesses oncogenic or oncolytic potential in influencing tumor progression. Therefore, it is important to evaluate the clinical and functional role of SARS-CoV-2 on tumor progression.
oncology,biochemistry & molecular biology
What problem does this paper attempt to address?